Statins lower pneumonia death risk in study

Share this article:
Cholestreol-lowering statin drugs can also reduce the risk of death by pneumonia in hospitalized patients, according to a study published this week in the journal Respiratory Research.
Researchers from the University of Texas Health Science Center at San Antonio found that pneumonia patients taking a cholesterol lowering statin such as Lipitor or Zocor when they entered the hospital were 2.8 times less likely to die from pneumonia than patients not taking the medications.
Statins are known to affect the immune system and that could explain their effect on pneumonia patients, the researchers speculated.
Pneumonia is the leading cause of death from infection in the United States, killing up to 40,000 people every year.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.